Arena Pharmaceuticals, Inc. EPS - Earnings per Share 2010-2021 | ARNA
Arena Pharmaceuticals, Inc. eps - earnings per share from 2010 to 2021. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Arena Pharmaceuticals, Inc. Annual EPS |
| 2021 |
$-10.14 |
| 2020 |
$-7.39 |
| 2019 |
$7.69 |
| 2018 |
$-0.63 |
| 2017 |
$-2.77 |
| 2016 |
$-0.93 |
| 2015 |
$-4.49 |
| 2014 |
$-2.80 |
| 2013 |
$-0.90 |
| 2012 |
$-4.50 |
| 2011 |
$-8.00 |
| 2010 |
$-11.40 |
| 2009 |
$-18.20 |
| Arena Pharmaceuticals, Inc. Quarterly EPS |
| 2021-12-31 |
$-2.55 |
| 2021-09-30 |
$-3.21 |
| 2021-06-30 |
$-2.40 |
| 2021-03-31 |
$-1.98 |
| 2020-12-31 |
$-2.09 |
| 2020-09-30 |
$-1.69 |
| 2020-06-30 |
$-1.61 |
| 2020-03-31 |
$-2.00 |
| 2019-12-31 |
$-1.71 |
| 2019-09-30 |
$-1.46 |
| 2019-06-30 |
$-1.24 |
| 2019-03-31 |
$12.10 |
| 2018-12-31 |
$1.52 |
| 2018-09-30 |
$-0.70 |
| 2018-06-30 |
$-0.65 |
| 2018-03-31 |
$-0.80 |
| 2017-12-31 |
$-0.24 |
| 2017-09-30 |
$-0.86 |
| 2017-06-30 |
$-0.77 |
| 2017-03-31 |
$-0.90 |
| 2016-12-31 |
$1.60 |
| 2016-09-30 |
$-0.51 |
| 2016-06-30 |
$-1.12 |
| 2016-03-31 |
$-0.90 |
| 2015-12-31 |
$-1.29 |
| 2015-09-30 |
$-1.10 |
| 2015-06-30 |
$-1.10 |
| 2015-03-31 |
$-1.00 |
| 2014-12-31 |
$-1.40 |
| 2014-09-30 |
$-0.50 |
| 2014-06-30 |
$0.30 |
| 2014-03-31 |
$-1.20 |
| 2013-12-31 |
$-1.00 |
| 2013-09-30 |
$-0.80 |
| 2013-06-30 |
$1.80 |
| 2013-03-31 |
$-0.90 |
| 2012-12-31 |
$-0.80 |
| 2012-09-30 |
$-0.70 |
| 2012-06-30 |
$-1.20 |
| 2012-03-31 |
$-1.80 |
| 2011-12-31 |
$-1.30 |
| 2011-09-30 |
$-1.60 |
| 2011-06-30 |
$-1.60 |
| 2011-03-31 |
$-3.50 |
| 2010-12-31 |
$-2.20 |
| 2010-09-30 |
$-3.10 |
| 2010-06-30 |
$-2.80 |
| 2010-03-31 |
$-3.30 |
| 2009-12-31 |
$-2.80 |
| 2009-09-30 |
$-3.80 |
| 2009-06-30 |
$-4.80 |
| 2009-03-31 |
$-6.80 |
